Answers are grounded in this paper and cite their sources.
A short, chromatography-free, and scalable synthetic route to thrombin inhibitor 1, the active metabolite of the propionic ester prodrug AZD8165, has been developed. The key synthetic step involved cycloaddition of TMS–diazomethane and ethyl acrylate to give an intermediate racemic dihydropyrazole which was reacted with enantiomerically pure 4-fluoro mandelic acid chloride in a one-pot dynamic kinetic resolution (DKR) process.
No takes yet. Share an insight, caveat, or question.
Karlsson et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: